Notes: Data are subject to change as contracts are finalized.  For 2014, enhanced alternative plans may offer additional gap coverage which is calculated as the percentage of “generic” formulary products with coverage above and beyond the 2014 standard "generic" coverage gap cost-sharing benefit and/or the percentage of “brand” formulary products covered in addition to the coverage gap discount for applicable drugs.  Additional gap coverage levels are determined separately for formulary generic and brand products and are described as follows:   “All”: 100% of formulary drugs are covered through the gap, “Many”: ≥65% to <100% of formulary drugs are covered through the gap, “Some”: ≥10% to <65 % of formulary drugs are covered through the gap, “Few”: >0% to <10% of formulary drugs are covered through the gap (and must also be >15 "brand" products covered through the gap), “No Gap Coverage”:  0% of formulary drugs are covered through the gap (or ≤15 "brand" products covered through the gap).  A label of “All Formulary Drugs” is applied for plans that cover 100% of “generic” and 100% of “brand” products (either by covering all formulary drug products in the gap or by having no initial coverage limit).
Data as of October 21, 2013.  Includes 2014 approved contracts/plans.
2014 Medicare-Medicaid Plans
Sheet MMPs
Excel file 2014LandscapeSource file MMP 10212013.xls
mmp2014 data set up by Jean Roth , jroth@nber.org , 17 May 2015